Show
Sort by
-
Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo
-
6''-Modified alpha-GalCer analogs capable of establishing an extra interaction with Cd1d leading to a polarized Th1 response and superior tumor protection
-
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
-
Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid
-
- Journal Article
- A1
- open access
Synthesis and evaluation of amino-modified α-GalCer analogues
-
Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid
-
Synthesis of sphingosine- and sugar modified α-GalCer analogues : towards new immunomodulatory agents
(2010) -
The synthesis and in vivo evaluation of 2',2'-difluoro KRN7000
-
- Journal Article
- A1
- open access
6'-Derivatised α-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice
-
- Journal Article
- A1
- open access
Synthesis and in vitro evaluation of α-GalCer epimers